Cargando…
Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway
Sphingomyelin is a dominant sphingolipid in mammalian cells. Its production in the trans-Golgi traps cholesterol synthesized in the ER to promote formation of a sphingomyelin/sterol gradient along the secretory pathway. This gradient marks a fundamental transition in physical membrane properties tha...
Autores principales: | Sokoya, Tolulope, Parolek, Jan, Foged, Mads Møller, Danylchuk, Dmytro I, Bozan, Manuel, Sarkar, Bingshati, Hilderink, Angelika, Philippi, Michael, Botto, Lorenzo D, Terhal, Paulien A, Mäkitie, Outi, Piehler, Jacob, Kim, Yeongho, Burd, Christopher G, Klymchenko, Andrey S, Maeda, Kenji, Holthuis, Joost CM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531943/ https://www.ncbi.nlm.nih.gov/pubmed/36102623 http://dx.doi.org/10.7554/eLife.79278 |
Ejemplares similares
-
Ca(2+)-activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair
por: Niekamp, Patrick, et al.
Publicado: (2022) -
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance
por: Guo, Yifan, et al.
Publicado: (2021) -
Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma
por: Bilal, Fatima, et al.
Publicado: (2019) -
Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER
por: Vacaru, Ana M., et al.
Publicado: (2009) -
Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2
por: Pekkinen, Minna, et al.
Publicado: (2019)